Tenon Medical (NASDAQ:TNON – Get Free Report) is projected to release its earnings data before the market opens on Monday, March 10th. Analysts expect Tenon Medical to post earnings of ($3.77) per share and revenue of $0.90 million for the quarter.
Tenon Medical Stock Down 4.4 %
Shares of TNON stock opened at $1.30 on Friday. Tenon Medical has a 12 month low of $1.13 and a 12 month high of $15.79. The firm has a market cap of $4.08 million, a PE ratio of -0.05 and a beta of 1.89. The stock has a 50 day moving average of $1.63 and a 200-day moving average of $2.48.
Analysts Set New Price Targets
Separately, Maxim Group cut their price target on Tenon Medical from $22.00 to $8.00 and set a “buy” rating for the company in a report on Friday, November 15th.
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Featured Stories
- Five stocks we like better than Tenon Medical
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Is Myers Industries Poised for a Breakout?
- 3 Healthcare Dividend Stocks to Buy
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- What is a Bond Market Holiday? How to Invest and Trade
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
